Nanotechnology is a highly innovative field of development that researches and uses structures that are 50,000 times thinner than a human hair. Nanotechnology makes it possible to produce materials with completely new properties, benefits and functions for a wide variety of application areas. Because it is an emergent field of research, heated debate is taking place around the world on the opportunities and risks.
Merck is researching and developing nanomaterials. In Chemicals, the use of nanoscale materials makes it possible to improve products, develop products with new functionalities and properties, and increase efficiency in the use of resources and energy. In Pharmaceuticals, we are working with external partners to explore the use of nanomaterials to improve therapeutic options. Within the scope of European research projects, we are presently investigating the suitability of nanoparticles as vehicles for active pharmaceutical ingredients.
In addition to the opportunities that nanotechnology offers us, potential risks also deserve our particular attention. For this reason, we are engaged in intensive dialog on this topic with other companies, associations and the authorities. We follow the precautionary principle and take safety issues regarding nanomaterials seriously.
At the end of 2008, Merck implemented the Policy for Use and Handling of Nanomaterials. In 2010, we revised and refined this policy. This Group-wide policy governs the handling of nanomaterials, no matter whether in pharmaceutical and chemical laboratories, production, filling or warehouses. In manufacturing and processing products, we pay strict attention to compliance with all statutory regulations and other applicable standards, such as the guidelines of the German Federal Institute for Occupational Safety and Health (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, BAuA) as well as the German Chemical Industry Association (Verband der Chemischen Industrie).
